<?xml version="1.0" encoding="UTF-8"?>
<p>There are no approved vaccines against ZIKV infection. Tebas et al. conducted a phase I clinical trial to evaluate the safety and efficacy of the DNA vaccine (GLS-5700) which encodes the premembrane and envelope proteins in healthy individuals. The vaccine elicited anti-ZIKV neutralizing antibodies in 62% of the samples on a cellular assay (Tebas et al., 
 <xref rid="B205" ref-type="bibr">2017</xref>). There are some phase I and II clinical trials on ZIKV vaccine. However, the preliminary results will be available a couple of years from now.
</p>
